2023-11-24T12:11:56+08:002020-02-14|
聯絡信息
教學
Education
Ph.D. University of Toronto
M.D. University of Toronto
Positions
2015-present Adjunct Distinguished Professor, Faculty of Health Sciences, University of Macau
2014-2015 Distinguished Professor, Faculty of Health Sciences, University of Macau
Research Interests
Immune thrombocytopenia
Leukemia, Myelodysplastic syndrome
Thombosis, Transfusion medicine
Representative Publications
  • Gregory Cheng, Mansoor N. Saleh, Claus Marcher, Sandra Vasey, Bhabita Mayer, Manuel Aivado, Michael Arning, Nicole L. Stone, James B. Bussel. Eltrombopag for the Management of Chronic Immune Thrombocytopenia: a 6-month, Randomised, Phase III Study (RAISE). Lancet. 2011 Jan 29;377(9763):393-402.
  • Yunfeng Cheng, Raymond S.M. Wong, Yannie O.Y. Soo, Chung Hin Chui, Fung Yi Lau, Natalie P.H. Chan, Wai Shan Wong, Gregory Cheng. Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone. NEJM 2003 Aug; 349:831-836.
  • Bussel J. B., Cheng G., Saleh M.N., Psaiia B., Kovaleva L., Meddeb B., Kloczko J., Hassani H., Mayer B., Stone N.L., Arning M., Provan D., Jenkins J.M. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura. NEJM 2007 Nov; 357: 2237-47.
  • Bussel B J; Provan D; Shamst T; Cheng Gregory; Psaila B; Kovaleva L; Salama A; Jenkins M J; Roychowdhury D; Mayer B; Stone N and Arning M.  “Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.”  Lancet vol.373 no.9664, pp.641-8. 2009.02.21.
  • Yunfeng Cheng, Gregory Cheng, CH Chui, FY Lau, Paul KS Chan, Margaret HL Ng, Joseph JY Sung, Raymond SM Wong. ABO Blood Group and Human Susceptibility to SARS. JAMA Vol. 293, no. 12:1450-51, 2005 Mar 05.
  • Kok Hon Lung Stanton; Wong Siu Ming Raymond; Gambari Roberto; Kok Hon Lung Stanton; Cheung Filly; Lam Wing Sze; Lau Fung Yi; Cheng Gregory;  “In vitro cytotoxicity of (-)-EGCG octaacetate on MDAMB-231 and SKHep-1 human carcinoma cells: a pharmacological consideration on prodrug design.”.  International Journal of Molecular Medicine vol.22 no.6, pp.841-845. 2008.12.
  • Cheng, G. Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?. Clinical Investigation 2015,5,3, 287-296.
Research Grants
(1) “A pilot study to evaluate the safety and efficacy of eltrombopag plus pulsed dexamethasone as first line therapy for subjects with idiopathic thrombocytopenic purpura (ITP) “
Patents
Transfusion wristband to improve transfusion safety
Awards
Best Teacher for Year 3 (CUHK) (2002, 2004, 2005, 2011)
Best Teacher for Year 5 (CUHK) (2000, 2001,2002,2004,2005)
Vice-Chancellor’s Exemplary Teaching Award (CUHK) (2001, 2005)
Master Teacher (CUHK) (2005)
Professional Activities
 Council Member  HK Association of Blood Transfusion & Haematology
 Council Member  Leukaemia Patient Support Group